Authors:
Kaabachi, O
Nessib, MN
Kechrid, A
Jelel, C
Ben Gachem, M
Citation: O. Kaabachi et al., Bacteriology of osteoarticular infections in infant: the experience of theorthopaedic unit of the children's hospital ot Tunis, MED MAL INF, 31(9), 2001, pp. 569-570
Authors:
Akoua-Koffi, C
Anghui, H
Faye-Kette, H
Eholie, S
Timite, M
Dosso, M
Kadio, A
Citation: C. Akoua-koffi et al., Bacteriological aspects of purulent meningitis in the Yopougon university hospital, 1995-1998., MED MAL INF, 31(7-8), 2001, pp. 475-481
Authors:
Akoua-Koffi, C
Anghui, H
Faye-Kette, H
Eholie, S
Timite, M
Dosso, M
Kadio, A
Citation: C. Akoua-koffi et al., Bacteriological aspects of purulent meningitis in the Yopougon university hospital, 1995-1998, MED MAL INF, 31(7-8), 2001, pp. 482-487
Authors:
Chibani, A
Zouhdi, M
El Messoui, M
Alaoui, MA
Elyachioui, M
Citation: A. Chibani et al., Bacteriologic study on the prevalence of healthy carriers of Salmonella inbutcher shop employees in the city of Kenitra and in kitchen employees of Rabat's hospitals, MED MAL INF, 31(7-8), 2001, pp. 508-510
Citation: Y. Mouton et C. Chidiac, Review of the 4th Consensus Conference on anti-infectious Therapy of the Societe de Pathologie Infectieuse de Langue Francaise (SPILF). Management ofLower Respiratory Tract Infections, MED MAL INF, 31(5), 2001, pp. 267-267
Citation: Should we use antibiotics to treat acute bronchitis in the healthy adult or acutely exacerbated chronic bronchitis in the patient without respiratorydistress syndrome, MED MAL INF, 31(5), 2001, pp. 339-343
Citation: What should constitute first-line antibiotic treatment of community-acquired acute pneumonia - How should it account for pneumococcal resistance in the case of failure, given the evolution of the pathogens responsible, and would that justify combined drug therapy?, MED MAL INF, 31(5), 2001, pp. 344-351
Citation: Should acute bronchitis in the healthy adult or chronic bronchitis in a non respiratory deficient patient be treated by antibiotherapy? Which molecule should be used? In what type of patient?, MED MAL INF, 31(5), 2001, pp. 352-356
Citation: What should the initial antibiotherapy for acute community acquired pneumonia be? How should it be reassessed in case of failure, given the evolutionof responsible pathogens and the resistance of pneumococci? Should combined treatment be used?, MED MAL INF, 31(5), 2001, pp. 357-363